CoChat

Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study

Ruiz de Adana, Maria S., Alhambra-Expósito, Maria Rosa, Muñoz-Garach, Araceli, Gonzalez-Molero, Inmaculada, Colomo, Natalia, Torres-Barea, Isabel, Aguilar-Diosdado, Manuel, Carral, Florentino, Serrano, Manuel, Martínez-Brocca, Maria A., Duran, Ana, Palomares, Rafael · 2020 · Diabetes Care

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients’ health-related quality of life (HRQoL), and physicians’ satisfaction in patients with type 1 diabetes. RESEARCH DESIGN AND METHODS: PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c <8% [<64 mmol/mol]), treated with multiple daily injections. A total of 388 patients were assessed for eligibility; 379 of them were randomized 1:1 to three face-to-face visits (control cohort [CC]) (n = 167) or the replacement of an intermediate face-to-face visit by a telemedicine visit using Diabetic (intervention cohort [IC]) (n = 163). The primary efficacy end point was the mean change of HbA1c levels from baseline to month 6. Other efficacy and safety end points were mean blood glucose, glucose variability, episodes of hypoglycemia and hyperglycemia, patient-reported outcomes, and physicians’ satisfaction. RESULTS: At month 6, the mean change in HbA1c levels was −0.04 ± 0.5% (−0.5 ± 5.8 mmol/mol) in the CC and 0.01 ± 0.6% (0.1 ± 6.0 mmol/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c <7% (<53 mmol/mol) was 73 and 78 in the CC and IC, respectively. Significant differences were not found regarding safety end points at 6 months. Changes in HRQoL between the first visit and final visit did not differ between cohorts, and, regarding fear of hypoglycemia (FH-15 score ≥28), statistically significant differences observed at baseline remained unchanged at 6 months (P < 0.05). CONCLUSIONS: The use of telemedicine in patients with type 1 diabetes with HbA1c <8% (<64 mmol/mol) provides similar efficacy and safety outcomes as face-to-face visits.

Overview

Integrity signals

Registry

Crossref · 10.2337/dc19-0739

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Research works printed but not linked: 4

  1. World Health Organization, 2010, Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009
  2. European Medicines Agency, 2016, Guideline for Good Clinical Practice E6(R2), 1
  3. Ruiz de Adana, 2012, High inflammatory markers in subjects with type 1 diabetes and its relationship with diabetes-related complications and insulin treatment, Av Diabetol, 28, 1
  4. StataCorp, 2015, Stata Statistical Software: Release 14

Cited by

Metadata

Authors
Ruiz de Adana, M. S., Alhambra-Expósito, M. R., Muñoz-Garach, A., Gonzalez-Molero, I., Colomo, N., Torres-Barea, I., Aguilar-Diosdado, M., Carral, F., Serrano, M., Martínez-Brocca, M. A., Duran, A., & Palomares, R.
Affiliations
  • Endocrinology and Nutrition Department, Hospital Regional Universitario de Málaga, Málaga, Spain
  • Endocrinology and Nutrition Department, Hospital Universitario Reina Sofía, Córdoba, Spain
  • Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
  • Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
  • Hospital Universitario de Jerez (ES)
  • Endocrinology and Nutrition Department, Hospital Universitario Puerta del Mar, Cádiz, Spain
  • Hospital Universitario Puerto Real (ES)
  • Complejo Hospitalario de Jaén (ES)
  • Endocrinology and Nutrition Department, Hospital Universitario Virgen Macarena, Sevilla, Spain
  • Sanofi (Spain) (ES)
  • Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
Corresponding author
Colomo, Natalia
Venue
Diabetes Care
Published
2019-12-12
Volume
43
Issue
2
Pages
337-342
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2996438223
Cited by
53
References
25
Citations by year
2025: 5 · 2024: 13 · 2023: 10 · 2022: 10 · 2021: 8 · 2020: 7
FWCI
5.75
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion)
Funders
Andalusian Society of Endocrinology, Diabetes, and Nutrition
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
telemedicine, HbA1c, glycemic control, multiple daily insulin injections, health-related quality of life, fear of hypoglycemia, hypoglycemia, glycemic variability, physician satisfaction, Andalusia, patient-reported outcomes
MeSH terms
Adult, Blood Glucose, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Injections, Insulin, Male, Middle Aged, Office Visits, Primary Health Care, Quality of Life, Spain, Treatment Outcome, Telemedicine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.